医学临床研究
   Jul. 7, 2025    Home  |  About Journal  |  Editorial Board  |  Instruction  |  Subscribe  |  Advertisement  |  Messages Board  |  Contact Us  |  中文
JOURNAL OF CLINICAL RESEARCH  2025, Vol. 42 Issue (5): 799-801    DOI: 10.3969/j.issn.1671-7171.2025.05.018
Original Articles Current Issue | Archive | Adv Search |
Clinical Efficacy of Pyrotinib Combined with TP Regimen in the Treatment of Breast Cancer
SHI Yushuai, YUE Saichao
Department of General Surgery Ⅰ, Xiangcheng First People's Hospital, Xiangcheng Henan 466200
Download: PDF (1165 KB)   HTML (1 KB) 
Export: BibTeX | EndNote (RIS)      
Abstract  【Objective】 To explore the efficacy of pyrotinib combined with the TP regimen (paclitaxel plus cisplatin) in the treatment of breast cancer patients.【Methods】 A total of 100 breast cancer patients were divided into the control group and the observation group based on different treatment regimens, with 50 cases in each group. The control group received the TP regimen, while the observation group was treated with pyrotinib combined with the TP regimen. The clinical application effects of different treatment regimens were compared between the two groups.【Results】 The disease control rate, post-treatment serum microRNA-22-3P (miR-22-3P) level, immune indicators CD4+, CD4+/CD8+ ratio, progression-free survival, and overall survival in the observation group were all higher than those in the control group (P<0.05). Meanwhile, the post-treatment cysteine-rich protein 61 (CYR61) level and CD8+ level in the observation group were lower than those in the control group (P<0.05).【Conclusion】 Pyrotinib combined with the TP regimen for breast cancer treatment can effectively increase serum miR-22-3P level, reduce CYR61 level, continuously improve immune function, prolong progression-free survival and overall survival, and it has good safety.
Key wordsBreast Neoplasms      Antineoplastic Combined Chemotherapy Protocols      Treatment Outcome     
Received: 01 August 2024     
PACS:  R737.9  
Service
E-mail this article
Add to my bookshelf
Add to citation manager
E-mail Alert
RSS
Articles by authors
SHI Yushuai
YUE Saichao
Cite this article:   
SHI Yushuai,YUE Saichao. Clinical Efficacy of Pyrotinib Combined with TP Regimen in the Treatment of Breast Cancer[J]. JOURNAL OF CLINICAL RESEARCH, 2025, 42(5): 799-801.
URL:  
http://journal07.magtech.org.cn/yxlcyj/EN/10.3969/j.issn.1671-7171.2025.05.018     OR     http://journal07.magtech.org.cn/yxlcyj/EN/Y2025/V42/I5/799
Copyright © Editorial Board of JOURNAL OF CLINICAL RESEARCH
Supported by:Beijing Magtech